NetraMark Holdings (XCNQ:AIAI) Institutional Ownership : 0.71% (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NetraMark Holdings's institutional ownership is 0.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NetraMark Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NetraMark Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.

NetraMark Holdings Institutional Ownership Historical Data

The historical data trend for NetraMark Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Institutional Ownership Chart

NetraMark Holdings Historical Data

The historical data trend for NetraMark Holdings can be seen below:

	2021-11-30	2021-12-31	2022-01-31	2022-02-28	2022-03-31
Institutional Ownership	0.89	0.74	0.74	0.74	0.71

NetraMark Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

NetraMark Holdings (XCNQ:AIAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

AINMF:USA

Address

1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1

Website

https://www.nurosene.com

NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.

Executives

Andrew Parks

Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines